In pancreatic cancer, LAT2 ( SLC7A8 ) was shown to decrease gemcitabine sensitivity by regulating glutamine-dependent mTOR activation to promote proliferation and inhibit apoptosis (Feng et al., 2018)
G2 (adenine + streptozotocin): received an intraperitoneal dose of 50 mg/kg of streptozotocin, dissolved in 0.1 M citrate buffer (pH 4.5), to induce DM and then adenine 0.25% w/w in the feed for 4 weeks to induce CKD
After dislodging, rosettes were incubated in wells coated with 0.2% porcine gelatin to allow the non-neural cells to differentially attach 21
BPC 157 treatment led to the upregulation of Egr1, Akt1, Kras, Src, Foxo, Srf, Vegfr2, Nos3, and Nos1 and the downregulation of Nos2 and Nfkb compared with untreated rats